Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
EKSO BIONICS (EKSO)
NASDAQ:EKSO
Holding EKSO?
Track your performance easily
Earnings Data
Report Date
Feb 27, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.08Last Year’s EPS
-$0.22Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 28, 2024
|% Change Since: -48.67%
|Next Earnings Date:Feb 27, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in CMS claim approval and international sales growth, with improved gross margins and reduced operating expenses, leading to a reduced net loss. However, revenue declined year-over-year with challenges in U.S. sales and the industrial segment.Company Guidance
During the EKSO Q3 2024 earnings call, the company highlighted several key metrics reflecting its strategic progress and financial performance. EKSO achieved quarterly sales of $4.1 million with 33 EksoHealth devices sold, marking a significant milestone with the CMS approval for their Ekso Indego Personal device. The company experienced strong demand internationally, particularly in Europe, where sales hit record levels, although U.S. sales were impacted by procurement cycle fluctuations and capital purchase delays. Gross profit for the quarter was $2.2 million, resulting in a gross margin of 53.5%, slightly up from 53.3% the previous year, while operating expenses decreased to $4.8 million from $5.4 million due to reduced headcount and discretionary costs. The net loss applicable to common stockholders decreased to $2.1 million or $0.10 per share, compared to $3.4 million or $0.24 per share in the same quarter of 2023. For the first nine months of 2024, EKSO's revenue totaled $12.8 million with a gross margin improvement to 53%. Cash and restricted cash stood at $8.3 million, bolstered by a public offering that raised approximately $5 million. The company is optimistic about its pipeline and future growth prospects, particularly as procurement cycles with IDNs normalize.CMS Claim Approval
The approval and reimbursement of the initial CMS claim for the Ekso Indego Personal, impacting thousands of Medicare and Medicaid patients with spinal cord injuries.
Increased Global Demand
Sales in Europe achieved record levels in the quarter with strong demand in NeuroRehabilitation centers.
Gross Margin Improvement
Gross margin increased to 53.5% in Q3 2024 from 53.3% in Q3 2023 due to cost savings in supply chain and reduced service costs.
Reduced Operating Expenses
Operating expenses decreased to $4.8 million in Q3 2024 from $5.4 million in Q3 2023.
Net Loss Reduction
Net loss decreased to $2.1 million in Q3 2024 from $3.4 million in Q3 2023.
---
EKSO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
EKSO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 28, 2024 | $1.13 | $0.96 | -15.04% |
| Jul 29, 2024 | $1.48 | $1.06 | -28.38% |
| Apr 29, 2024 | $1.29 | $1.24 | -3.88% |
| Mar 04, 2024 | $2.10 | $1.58 | -24.76% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does EKSO BIONICS (EKSO) report earnings?
EKSO BIONICS (EKSO) is schdueled to report earning on Feb 27, 2025, TBA Not Confirmed.
What is EKSO BIONICS (EKSO) earnings time?
EKSO BIONICS (EKSO) earnings time is at Feb 27, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is EKSO EPS forecast?
EKSO EPS forecast for the fiscal quarter 2024 (Q4) is -$0.08.
---